University of Colorado Awarded US Patent for Cancer Rx; Viral Genetics Holds Option to Tech

Viral Genetics holds an exclusive option to acquire the rights to the intellectual property, which adds to a portfolio of IP the company had previously licensed from CU, but represents a new direction for an ongoing collaborative research partnership between the entities.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.